Hemenway Trust CO LLC Novartis Ag Transaction History

Hemenway Trust CO LLC

  • $1.19 Billion
  • Q3 2024

A detailed history of Hemenway Trust CO LLC transactions in Novartis Ag stock. As of the latest transaction made, Hemenway Trust CO LLC holds 11,189 shares of NVS stock, worth $1.1 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
11,189
Previous 19,980 44.0%
Holding current value
$1.1 Million
Previous $2.13 Million 39.54%
% of portfolio
0.11%
Previous 0.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$106.13 - $120.89 $932,988 - $1.06 Million
-8,791 Reduced 44.0%
11,189 $1.29 Million
Q2 2024

Aug 05, 2024
SELL
$92.57 - $107.37 $6.45 Million - $7.49 Million
-69,731 Reduced 77.73%
19,980 $2.13 Million
Q1 2024

May 03, 2024
SELL
$95.27 - $108.47 $6.87 Million - $7.82 Million
-72,114 Reduced 44.56%
89,711 $8.68 Million
Q4 2023

Feb 12, 2024
SELL
$92.27 - $101.54 $2.79 Million - $3.07 Million
-30,187 Reduced 15.72%
161,825 $16.3 Million
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $19,419 - $21,551
205 Added 0.11%
192,012 $19.6 Million
Q2 2023

Aug 11, 2023
BUY
$92.52 - $104.91 $445,021 - $504,617
4,810 Added 2.57%
191,807 $19.4 Million
Q1 2023

May 10, 2023
BUY
$80.03 - $92.81 $166,462 - $193,044
2,080 Added 1.12%
186,997 $17.2 Million
Q4 2022

Feb 08, 2023
SELL
$75.55 - $92.52 $288,978 - $353,889
-3,825 Reduced 2.03%
184,917 $16.8 Million
Q3 2022

Nov 08, 2022
SELL
$74.61 - $87.26 $34,917 - $40,837
-468 Reduced 0.25%
188,742 $14.3 Million
Q2 2022

Jul 19, 2022
SELL
$80.52 - $93.75 $1.16 Million - $1.35 Million
-14,396 Reduced 7.07%
189,210 $16 Million
Q1 2022

May 16, 2022
SELL
$80.11 - $90.62 $302,094 - $341,728
-3,771 Reduced 1.82%
203,606 $17.9 Million
Q4 2021

Feb 08, 2022
SELL
$79.7 - $88.13 $1.04 Million - $1.15 Million
-13,054 Reduced 5.92%
207,377 $18.1 Million
Q3 2021

Nov 10, 2021
SELL
$81.78 - $95.14 $440,303 - $512,233
-5,384 Reduced 2.38%
220,431 $18 Million
Q2 2021

Aug 09, 2021
SELL
$85.24 - $94.15 $292,714 - $323,311
-3,434 Reduced 1.5%
225,815 $20.6 Million
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $613,057 - $722,966
7,342 Added 3.31%
229,249 $19.6 Million
Q4 2020

Feb 16, 2021
BUY
$78.07 - $94.43 $408,696 - $494,341
5,235 Added 2.42%
221,907 $21 Million
Q3 2020

Oct 28, 2020
BUY
$82.14 - $91.0 $115,160 - $127,582
1,402 Added 0.65%
216,672 $18.8 Million
Q2 2020

Jul 28, 2020
BUY
$80.93 - $91.1 $329,304 - $370,685
4,069 Added 1.93%
215,270 $18.8 Million
Q1 2020

May 07, 2020
BUY
$70.67 - $99.01 $346,777 - $485,842
4,907 Added 2.38%
211,201 $17.4 Million
Q4 2019

Jan 15, 2020
BUY
$84.35 - $95.37 $102,991 - $116,446
1,221 Added 0.6%
206,294 $19.5 Million
Q3 2019

Nov 04, 2019
BUY
$85.54 - $94.26 $132,501 - $146,008
1,549 Added 0.76%
205,073 $17.8 Million
Q2 2019

Jul 24, 2019
BUY
$75.4 - $92.8 $108,726 - $133,817
1,442 Added 0.71%
203,524 $18.6 Million
Q1 2019

Apr 29, 2019
BUY
$75.32 - $86.15 $1.55 Million - $1.78 Million
20,629 Added 11.37%
202,082 $19.4 Million
Q4 2018

Jan 24, 2019
SELL
$73.66 - $82.02 $845,395 - $941,343
-11,477 Reduced 5.95%
181,453 $15.6 Million
Q3 2018

Oct 15, 2018
BUY
$66.94 - $77.43 $328,742 - $380,258
4,911 Added 2.61%
192,930 $16.6 Million
Q2 2018

Jul 30, 2018
BUY
$64.91 - $73.36 $706,480 - $798,450
10,884 Added 6.14%
188,019 $14.2 Million
Q1 2018

Apr 24, 2018
BUY
$70.39 - $84.15 $494,208 - $590,817
7,021 Added 4.13%
177,135 $14.3 Million
Q4 2017

Feb 02, 2018
BUY
$72.33 - $77.64 $566,054 - $607,610
7,826 Added 4.82%
170,114 $14.3 Million
Q3 2017

Oct 26, 2017
BUY
$74.14 - $77.27 $12 Million - $12.5 Million
162,288
162,288 $13.9 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Hemenway Trust CO LLC Portfolio

Follow Hemenway Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemenway Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hemenway Trust CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email